Daptomycin resistance and treatment failure following vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE)

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 28, Issue 7, 2009, Pages 831-833

  Cunha, B A ^a,b   Pherez, F M ^a,b  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; DAPTOMYCIN; RIFAMPICIN; VANCOMYCIN;

AGED; ANAMNESIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; BRAIN HEMORRHAGE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; LEUKOCYTE COUNT; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MITRAL VALVE ACUTE BACTERIAL ENDOCARDITIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT DURATION;

AGED; ANTI-BACTERIAL AGENTS; DAPTOMYCIN; DRUG RESISTANCE, BACTERIAL; ENDOCARDITIS, BACTERIAL; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MITRAL VALVE; STAPHYLOCOCCAL INFECTIONS; TREATMENT FAILURE; VANCOMYCIN;

EID: 67349084361     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-008-0692-2     Document Type: Article

References (23)

1. Brusch JL (2007) In: Brusch JL (ed) Infective endocarditis: management in the era of intravascular devices. Informa Healthcare USA: New York, NY
2. N Kim J Lazar BA Cunha 1999 Temperatures ≥ 102°F as a prognostic feature of acute bacterial endocarditis Infect Dis Pract 23 90 92
3. LM Baddour WR Wilson AS Bayer 2005 Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America Circulation 111 394 434
4. BA Cunha 2006 Persistent S. aureus acute bacteremia: clinical pathway for diagnosis and treatment Antibiotic Clin 10 39 46
5. JF Acar LD Sabath 1978 Bacterial persistence in vivo: resistance or tolerance to antibiotics Scand J Infect Dis Supp 14 86 91 (Pubitemid 9043498)
6. BA Cunha AM Ortega 1995 Antibiotic failure Med Clin North Am 79 663 672
7. L Cui X Ma K Sato 2003 Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus J Clin Microbiol 41 5 14 (Pubitemid 36098547)
8. JB Patel LA Jevitt J Hageman 2006 An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus Clin Infect Dis 42 1652 1653 (Pubitemid 43752657)
9. G Sakoulas HS Gold RA Cohen 2006 Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia J Antimicrob Chemother 57 699 704
10. DJ Skiest 2006 Treatment failure resulting from resistance of Staphylococcus aureus aureus to daptomycin J Clin Microbiol 44 655 656 (Pubitemid 43222276)
11. PA Moise DS Smyth N El-Fawal 2008 Microbiological effects of prior vancomycin use in patients with methicillin-resistant Staphylococcus aureus bacteraemia Antimicrob Chemother 61 85 90
12. JW Bennett CK Murray RL Holmes 2008 Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus Diagn Microbiol Infect Dis 60 437 440
13. HW Boucher G Sakoulas 2007 Perspectives on daptomycin resistance, with emphasis on resistance in Staphylococcus aureus Clin Infect Dis 45 601 608 (Pubitemid 47328642)
14. M Sharma K Riederer P Chase 2008 High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aureus bacteremia Eur J Clin Microbiol Infect Dis 27 433 437 (Pubitemid 351713065)
15. G Sakoulas W Rose MJ Rybak 2008 Evaluation of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin J Clin Microbiol 46 220 224
16. WE Rose SN Leonard MJ Rybak 2008 Evaluation of daptomycin pharmacodynamics and resistance at various dosage regimens against Staphylococcus aureus isolates with reduced susceptibilities to daptomycin in an in vitro pharmacodynamic model with simulated endocardial vegetations Antimicrob Agents Chemother 52 3061 3067
17. BA Cunha 2008 Vancomycin revisited: a reappraisal of clinical use Crit Care Clin 24 394 420
18. BA Cunha NS Hamid H Kessler 2005 Daptomycin cure after cefazolin treatment failure of methicillin-sensitive Staphylococcus aureus (MSSA) tricuspid valve acute bacterial endocarditis from a peripherally inserted central catheter (PICC) line Heart Lung 34 442 47
19. BA Cunha LE Eisenstein NS Hamid 2006 Pacemaker-induced Staphylococcus aureus mitral valve acute bacterial endocarditis complicated by persistent bacteremia from a coronary stent: cure with prolonged/high-dose daptomycin without toxicity Heart Lung 35 207 211
20. DN Salem HD Daudelin HJ Levine 2001 Antithrombotic therapy in valvular heart disease Chest 119 207 219
21. R Khatib S Saeed M Sharma 2006 Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia Eur J Clin Microbiol Infect Dis 25 181 185
22. RN Jones 2008 Key considerations in the treatment of complicated staphylococcal infections Clin Microbiol Infect 14 3 9
23. BA Cunha 2005 Clinical manifestations and antimicrobial therapy of methicillin resistant Staphylococcus aureus (MRSA) Clin Microbiol Infect 11 33 42 (Pubitemid 40946170)